相关实验视频

Updated: Sep 14, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

哪种1型糖尿病内型型最适合用于抗CD3抗体预防试验?

Maria Aurora Roma Wilson¹, Paolo Pozzilli²

¹Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Journal of diabetes and its complications

|July 20, 2025

概括

特普利祖马布可以延缓1型糖尿病 (T1D) 的进展,特别是在具有侵略性内型的年轻患者中. 根据特定的T1D内型来定制预防试验可以优化治疗效益和胰岛素生产.

科学领域:

免疫学免疫学免疫学
内分泌学在内分泌学.
临床试验设计临床试验设计

背景情况:

1型糖尿病 (T1D) 是一种异质的自身免疫性疾病,具有不同的内型.
作为一种抗CD3单克隆抗体,Teplizumab在延缓T1D进展方面表现有前途.
对特普利祖马布的治疗反应因T1D内型而异.

研究的目的:

评估不同T1D内型的适合性,用于特普利祖马布预防试验.
专注于早期发病的T1D内型 (T1DE1和T1DE2).
评估特普利祖马布对疾病进展和胰岛素生产的影响.

主要方法:

临床试验数据对Teplizumab在T1D疗效的审查.
分析T1D内型特征及其对免疫治疗的反应.
对特定年龄的反应和免疫活动标志物的评估.

主要成果:

15岁以下的个体具有高免疫活性,表现出对T1D进展的最显著延迟.
特普利祖马布可能会将患者从快速进展的T1DE1转移到较慢的T1DE2轨迹.
这种转变可能会延长功能性胰岛素的产生,并改善代谢结果.

结论:

针对内型特异的预防试验对于优化teplizumab疗效至关重要.
早期查和识别高风险个体至关重要.
进一步的研究应侧重于年轻人群和预测生物标志物,以实现个性化的T1D管理.

关键词:

这是一种C-.内型类型的内型类型异质性异质性异质性免疫治疗是一种免疫疗法.这就是Teplizumab.1 型糖尿病 1 型糖尿病

更多相关视频

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

相关概念视频

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...